1. J. M. Buesa-Perez, A. Leyva and H. M. Pinedo, Effect of methotrexate on 5-phosphoribosyl-1-pyrophosphate levels in L1210 leukemia cells in vitro; Cancer Res. 40: 139 (1980).
2. E. Cadman, R. Heimer and L. Davis, Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism, Science 205: 1135 (1979).
3. J. P. M. Bökkerink, T. J. Schouten, R. A. De Abreu, R. J. Lippens, G. A. M. de Vaan, C. H. M. M. de Bruijn en J. P. R. M. van Laar-hoven, 6-Mercaptopurine en methotrexate, zicht op een rationeel gebruik na 35 jaar?, T.Kindergeneesk. 52: 118 (1984).
4. J. P. M. Bökkerink, R. A. De Abreu, J. P. R. M. van Laarhoven, M. A. H. Bakker, T. W. Hulscher, E. D. A. M. Schretlen and C. H. M. M. de Bruijn, Increased availability of phosphoribosyl pyrophosphate as the basis for enhanced 6-mercaptopurine incorporation by methotrexate, in cultured human lymphoblasts, submitted for publication in: Purine Metabolism in Man-V.
5. R. A. De Abreu, J. P. M. Bökkerink, M. A. H. Bakker, T. W. Hulscher, J. M. van Baal, C. H. M. M. de Bruijn and E. D. A. M. Schretlen, Influence of methotrexate on purine and pyrimidine pools and on cell phase distribution of cultured human lymphoblasts, Submitted for publication in: Purine Metabolism in Man-V.